Abnormal albumin excretion after two provocative renal tests in diabetes: Physical exercise and lysine injection  by Mogensen, Carl Erik et al.
Kidney International, Vol. 16 (1979), pp. 385—393
Abnormal albumin excretion after two provocative renal
tests in diabetes: Physical exercise and lysine injection
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Proteinuria, the first clinical sign of nephropathy,
is generally not found during the first 10 to 15 years
of diabetes mellitus. Using a sensitive radioimmu-
noassay for albumin, we also found normal excre-
tion values in almost all patients in generally good
diabetes control for the first many years of the dis-
ease [1-3]. Morphological changes in the kidney oc-
cur, however, very early in diabetes [4], and recent-
ly we showed that examinations during physical ex-
ercise disclose abnormalities in albumin excretion
in patients with normal baseline values [5]. The evo-
lution of changes and the involved mechanisms
were, however, not established.
Analysis of the final urine does not permit deter-
mination of the glomerular passage rate of albumin
or any other protein, because unknown amounts of
plasma proteins are reabsorbed by the proximal
tubular cells. The discovery that arginine, lysine,
and certain other amino acids inhibit tubular protein
reabsorption opened, however, new possibilities in
this field [6—8].
The aim of the present study was two-fold; name-
ly, to examine more closely the development and
mechanism of the abnormalities in albumin excre-
tion emerging during exercise in diabetes and to
evaluate a new kind of provocation test for protein
excretion in similar groups of patients—that is, inhi-
bition of tubular protein reabsorption by the use of
lysine, the most strongly inhibiting substance exam-
ined so far [7].
Methods
Exercise test: Patients and normal controls,
Thirty-seven male, insulin-dependent, nonobese,
juvenile diabetic patients were examined. Data are
shown in Table 1. These patients were divided into
four groups according to the duration of diabetes
and basal albumin excretion. In 6 patients (group
A), the duration of diabetes was less than 1 year. In
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patients of groups B and C, the duration of diabetes
was 2 to 12 years and more than 15 years, respec-
tively. These patients had normal albumin excre-
tion. All patients in group D had elevated basal
albumin excretion rates, measured on several occa-
sions, ranging from 25 to 88 jsg/min. Earlier obser-
vations in our diabetes clinic has shown that they
were negative or trace-positive on Albustix® test-
ing.
Mild retinopathy in the form of red dots and dila-
tated veins were found in 2 patients in group C and
in 3 patients in group D. Retinopathy was not found
in groups A and B. All were examined as out-
patients in their usual control situation. Mean
plasma glucose concentrations in the groups varied
from 147 to 178 mgIlOO ml.
All patients had normal serum creatinine concen-
trations. GFR was measured in 14 of the patients
and was elevated as described earlier [2, 3].
Eleven normal male subjects (medical students
and doctors) served as control subjects. Their mean
age was 27.3 years, very similar to that of the pa-
tients.
Procedure during exercise test. Patients and con-
trol subjects came to the laboratory around 8 A.M.
All were fasting over night and the patients with dia-
betes did not take their morning insulin dose until
termination of the test. A scheme of the experimen-
tal setup is shown in Fig. 1. All subjects first rested
in the sitting position for about 2 hours, drinking 250
ml of water every 20 mm to increase urinary output.
Urine samples from this period were discarded.
Water-drinking was continued unchanged through-
out the test. The experimental period started with
two urine collection periods in the resting, pre-
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Table 1. Subjects investigated by exercise testa
Group
Age
years
Diabetes duration
years
Plasma glucose
mg/tOO ml
Normal subjects (N 11)
A(DD 1 yr;N = 6)
B (DD, 2 to 12 yr; N = 18)
C(DD l5yr;N = 7)
D(1 basal Uaib;N = 6)
27.3 3.4
25.5
27.4 5.0
29.4 3.2
24.0 3.8
—
0.5
_i)
5.6 2.3 (2.5—11)
17.6 1.6 (16-20)
12.2 3.3 (7—17)
—
147 50
158 55
178 61
166 P 60
a Values are the means SD. DD is diabetes duration. N denotes number of subjects.
exercise state in the sitting position, followed by
two exercise periods on a bicycle ergometer, the
exercise load in the first being 450 kpm/min; in
the second, 600 kpmlmin. Thereafter, three post-
exercise periods were taken. Each period lasted
20 mm. In 5 normal subjects and 6 patients with
diabetes, the exercise period at 600 kpm!min was
extended to 30 mm. Heart rate and auscultatory
blood pressure were measured at regular intervals
three times during the second preexercise period
and three times during each exercise period. Only
systolic pressures were measurable during exercise.
Lysine test: Patients and normal controls. Thirty-
two male, insulin-dependent, juvenile diabetics
were examined. Data are shown in Table 2. These
patients were divided into four groups (groups B to
E) according to the duration of diabetes and basal
albumin excretion and with the same lettering as in
the exercise experiments. The patients in groups B
and C (with normal albumin excretion) had diabetes
2 to 12 years and 14 years or more duration, re-
spectively. All patients in groups D and E had an
elevated basal albumin excretion rate on several
occasions, ranging from 25 to 100 jxglmin and 101
to 300 xglmin, respectively. Group D was negative
or trace-positive according to earlier examinations
with the Albustix test. Group E was trace-positive.
Mild retinopathy in the form of red dots and dila-
tated veins were found in 4 patients in group C, 2
in group D, and 3 patients in group E. One patient
in group C and one in group E had proliferative
lesions. All were examined as outpatients. All pa-
tients, including groups D and E had normal serum
creatinine concentrations. GFR was measured in 12
of the patients and was elevated as described ear-
lier [2, 3]. Nine normal male subjects of approxi-
mately the same age as the patients (medical stu-
dents and doctors) served as control subjects.
Procedure during lysine test. The same proce-
dure as in the exercise experiment was used with 2
hours at rest, drinking water, and two resting base-
line preperiods. The only difference was that the
subjects were supine during the entire test, except
when voiding. After two baseline periods, lysine
was given during a third period, all periods being at
20 mm intervals. Using a 33% solution of lysine, we
gave 0.4 glkg body wt i.v. during 10 mm in the
middle of this third period. After the injection peri-
od, seven postinjection periods followed. These pe-
riods also lasted 20 mm each except for the final
Start
drinking water
every 20 mm
—120
PRE EXERCISE POST
kpm/m in
1 2 450i600
0 20 40 60 80
Heart rate
Blood pressure
Albumin excretion
Light chains excretion
82-microglobulin excretion
Fig. 1. Experimental setup of the exercise test.
1 2 3 periods
100 120 140 mm
xxx xxx xxx Heart rate and
blood pressure
• • • 1 1 1 1 I 1 1 I Water drinking
o a a o o 0 0 a a a Urine voiding
thrown away
Parameters measured:
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Table 2. Subjects investigated by lysine testa
Age Diabetes duration Plasma glucose
Group years years mg/100 ml
Normal subjects (N = 9) 27.3 5.3 — —
B(DD2to l2yr;N = 8) 27.6 6.8 7.3 2.9(2.5—12) 169 63
C(DD l4yr;N = 14) 29.4 5.7 17.6 2.9(14-25) 148 75
D (basal albumin excretion, 25 to 100 ig/min; N = 6) 31.8 5.7 16.7 5.0(13-23) 178 40
E(basalUalb, 101 to 300g/min;N = 4) 28.8 7.3 12.2 6.9(3-20) 226 106
a Values are the means + SD. DD is diabetes duration. N denotes number of subjects.
two, each lasting 30 mm. No untoward effect was crease in albumin excretion during exercise was
noted in any of the subjects examined, found in normal persons, the mean excretion rate
Analytical methods. Urinary excretion of albu- being between 5.6 and 6.9 g/min during the entire
mm, light chains (kappa and lambda chains), and experimental procedure. Also, no increase was
beta-2-microglobulin (Phadebas® /3-2 micro test) found in the 6 diabetics with a duration of diabetes
were measured by radioimmunoassay [9-11]. We of 1 year or less. A significant increase was found in
added 10 1d of 20% bovine albumin (Ortho diagnos.. patients with diabetes of 2 to 12 year's duration
tics) to 7-ml urine samples to prevent absorption (group B), the maximal mean value occurring in the
of proteins to glass and plastic ware. first postexercise period. P values are shown in
Statistical methods. Rank sum test, with Geigy Table 3. Individual maximal values were found ei-
scientific tables, was used for statistical calculation ther in the period of 600 kpm!min or in the first exer-
of results of exercise experiments. Student's t test cise period. In the third postexercise period, the
was used for statistical calculations of the results of values were again normal. Even higher exercise-in-
the lysine test. duced increases were found in group C, where the
duration of diabetes was between 16 and 20 years.
Results Basal values were normal, but significant increases
were found during exercise and in the two post-
Exercise test exercise periods. When compared with normal sub-
Results regarding albumin, beta-2-microglobulin, jects, group C patients showed a significant increase
and light chain excretion rates before, during, and even at 450 kmp/min. When compared with pre-
after exercise are shown in Tables 3 to 5. exercise values, they showed significant increases
Albumin excretion. As shown in Table 3, no in- at 600 kpm/min. Again, excretion rate was totally
Table 3. Albumin excretion (g/min) before, during, and after exercisea
Maximal
increase
Before At 450 At 600 Postexercise Postexercise Postexercise (600 and I
Group exercise kpmlmin kpm/min period 1 period 2 period 3 postexercise)
Normal subjects 6.0 3.8 6.5 2.7 6.9 2.1 6.3 2.3 5.6 2.2 6.0 2.3 1.3 3.2
(2.3—14.0) (3.4—13.0) (3.8—10.2) (2.4—9.9) (3.5—10.6) (1.7—9.9) (—4.6—6.0)
A(DD 1 yr) 7.8 3.1 6.9 3.1 7.6 3.0 6.7 3.0 6.1 2.0 5.8 1.9 —0.1 2.1
(4.0—11.6) (4.4—12.5) (4.6—10.7) (2.6—10.7) (2.9-8.4) (3.3—8.1) (—3.7—2.6)
B(DD,2to l2yr) 6.7 3.0 10.2 9.2 16.6 171g 19.8 23.4c,a 7.8 4.6e 7.3 5.8 17.0 219,g
(3.7—15.4) (2.6 — 31.2) (3.8—70.0) (3.5—87.6) (3.8—20.0) (2.7—23.3) (—0.8—72.2)
C(DD lSyr) 6.3 2.5 14.1 119b 26.5 263d,f 53.2 516d.e 10.9 33d,f 6.0 1.6 48.1 5l.2
(3.4—9.8) (4.9—33.9) (8.4—81.0) (6.8—125.7) (7.2—15.9) (3.6—8.7) (—0.4—118.6)
D(f basalUalb) 40.6 20.2" 64.3 47.3 113.2 ll9.9 105.7 36.3" 58.7 338d,e 38.4 21.1" 97.6 94.6"
(24.7—77.5) (26.4—143.4) (25.2—321.2) (41.0—143.0) (25.2—120.0) (17.0—73.8) (19,7—282.8)
8 Values are means SD. Ranges are given in parentheses. DD is diabetes duration.
b p < 0.05, different from normal values.
P < 0.025, different from normal values.
d P < 0.01, different from normal values.
U < 0.05, different from preexercise values.
P < 0.025, different from preexercise values.
P < 0.01, different from preexercise values.
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normal in the third postexercise period. In group D,
basal values were by definition increased. Signifi-
cant increases from preexercise values were found
even at 450 kpm/min and further at 600 kpm/min
and in the two postexercise periods. In the third
postexercise period, the excretion rate was at the
preexercise level. Figure 2 shows mean values of
the individual groups (A to C), and normal subjects
during the entire course of the experiments. Figure
3 shows results on all the individual subjects, sum-
marized by prevalues and maximal albumin excre-
tion, occurring either at 600 kpm/min or in the first
postexercise period.
Beta-2-microglobulin excretion (Table 4). No in-
crease during exercise was found either in normal
subjects or in any of the diabetic groups. Also base-
line values were normal although there was a ten-
dency to increased basal preexercise excretion
rates in groups C and D, but the difference was not
significant.
Light chains excretion (Table 5). As in the case of
beta-2-microglobulin, no increase was found during
exercise. Neither was any significant difference
found between normal subjects and patients with di-
abetes in the basal preexercise values.
Table 4. Beta-2-microglobulin excretion (ng/min) before, during, and after exercisea
Group Before exercise At 450 kpm/min At 600 kpm/min Postexercise period 1 Postexercise period 2
Normal subjects 47 27 47 30 45 24 47 25
(15—88) (11—91) (7—94) (12—93)
A(DD 1 year) 46 20 43 24 52 24 51 22
(22—66) (20—80) (23—86) (22—86)
B (DD, 2 to 12 yr) 56 42 56 29 47 22 54 28
(13—186) (9—124) (12—89) ( 8—117)
C (DD 15 yr) 197 181 145 113 186 167 101 75
(52—533) (45—333) (47—429) (33—255)
D(t basal Ua15) 109 124 85 58 77 46 104 42
(29—329) (25—164) (24—136) (38—143)
49 33
(15—114)
40 16
(5—58)
55 23
(10—100)
99 51
(41—194)
73 51
(28—146)
a Values are means SD. Ranges are given in parentheses. DD is diabetes duration.
TableS. Light chains excretion (mg/mm) before, during, and after exercisea
Group Before exercise At 450 kpmlmin At 600 kpmlmin Postexercise period 1 Postexercise period 2
Normal subjects 8.4 3.4 8.3 5.7 5.9 3.9 6.0 4.9
(5.2—14.3) (3.0—22.1) (2.2—15.5) (2.9—19.3)
A(DD 1 yr) 6.8 1.9 6.5 2.6 7.0 5.0 4.4 2.2
(4.4—9.7) (4.2-11.6) (2.4-16,1) (2.0—8.1)
B (DD, 2 to 12 yr) 6.2 1.9 5.7 3.6 5.8 3.8 6.7 2.9
(3.4—10.9) (1.4—16.3) (0.9—14.0) (2.1—14.2)
C(DD l5yr) 11.6 5.0 10.2 6.3 10.6 7.0 9.1 5.4
(4.1-19.6) (3.9—19.2) (2.5—20.8) (2.7—18.6)
D(t basalUalb) 6.5 1.1 6.7 1.7 6.1 1.9 7.1 2.3
(5.5—7.8) (5.4—9.1) (4.4—8.2) (4.5—9.2)
7.4 2.8
(3.5—12.0)
5.1 2.0
(2.8—7.7)
10.0 7.8
(3.1—12.8)
9.1 3.8
(3.0—13.7)
6.6 1.5
(4.8—8.0)
a Values are means SD. Ranges are given in parentheses. DD is diabetes duration.
72.7
Dc
50
1
Before exercise During exercise After exercise
Period 1 Period 2 j Period 1 Period 2 Period 3
450 kpm/min 600 kpm/min
Fig. 2. Mean urinary albumin excretion during exercise. We test-
ed 11 normal subjects (N), 6 patients having diabetes less than 1
year (DA), 18 patients having diabetes 2 to 11 years (DB), and 7
patients having diabetes 16 to 20 years (Dc).
N
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Heart rates (Table 6). The basal heart rate was at
the same level in normal subjects and in patients
with diabetes irrespective of duration of diabetes.
In the 7 patients having diabetes more than 15 years
(group C), the mean heart rate was higher during
Table 6. Heart rate before and during exercisea
Before At 450 At600
Group exercise kpmlmin kpm/min
Normal subjects 62 7.2 108 8.7 131 18.6
A (DD < I yr) 57 8.9 101 6.2 119 4.5
B(DD,2tol2yr) 62 7.8 112 8.6 133 9.8
C(DD lSyr) 62 9.4 121 14.1 150 19.1
D(t basal UaIb) 67 8.2 112 7.0 135 7.6
a Values are means SD. DD is diabetes duration.
exercise, but the difference failed to reach statistical
significance (2 P = 5.9%). No significant correlation
was found between increase in albumin excretion
and increase in heart rate within the diabetic
groups. Also when all patients with diabetes were
tested as one group, no correlation was established.
Blood pressure (Table 7). Preexercise systolic
and diastolic blood pressures were at the same level
in normal subjects and in the four groups of diabetic
patients. During exercise, mean values of systolic
pressure were higher in groups C and D, but the
difference was not significant. There was no signifi-
cant correlation between increase in systolic blood
pressure and increase in albumin excretion within
the individual diabetic groups. Considering, how-
ever, the 37 diabetics studied as one group, a signifi-
cant correlation was found (r = 0.64, 2 P < 0.001).
Lysine test
Table 8 shows increases in albumin, beta-2-mi-
croglobulin, and light chain excretion after lysine
injections in normal subjects and in groups B to E of
the diabetic patients. Abnormally high values in al-
bumin excretion after lysine injections were only
found in diabetic groups D and E, that is, in patients
with high baseline values. Peak excretion values oc-
curring in the first postinjection period are shown in
Fig. 4. The mean peak value for normal subjects
was 192.2 (SD) 39 p.glmin. Significantly higher
values were found in group D, namely 336.6 (SD)
107 gImin (2 P = 0.012), and in groups E, 633.1
(SD) 125 tg!min (2 P = 0.006). No significant
changes were found in groups B and C. No signifi-
cant correlation was found between peak excretion
values and baseline values in normal subjects and in
diabetic patients of groups B and C. Such a correla-
tion was found, however, in patients with elevated
baseline values (groups D and E), as seen in Fig. S.
The differences in peak excretion values and base-
line values in the 4 patients of group E were 504.2,
296.6, 431.5, and 525.0 jg/min, suggesting that the
proximal tubules are able to reabsorb at least these
Table 7. Blood pressure (mm Hg) before and during exercise
Group
Before exercise
450 kpmlmin
(systolic)
600 kpmlmin
(systolic)Systolic Diastolic
Normal subjects 122.5 14.0 79.0 12.2 147.5 18.0 157.0 20.2
A(DD < 1 yr) 118.3 6.8 74.2 7.4 139.2 5.8 150.0 6.3
B(DD,2tol2yr) 116.7 8.4 78.6 5.1 146.7 12.1 157.8 14.1
C(DD lSyr) 122.1 8.0 84.3 7.8 160.7 22.6 171.4 24.5
D(t basal UaIb) 118.3 6.8 83.3 7.5 154.0 15.2 172.0 12.0
a Values are means SD. DD is diabetes duration.
p = prevalue
[maximaI value
:1
D
100
60
20
321
p rn p m p m p m p m
N DA Dc D0
Fig. 3. Individual values of albumin excretion, namely prevalues
and maximal values. We tested II normal subjects (N), 6 pa-
tients with diabetes 1 year or less (DA), 18 patients with diabetes
2 to 11 years (D), 7 patients with diabetes 16 to 20 years (Dr),
and 6 patients with diabetes and with elevated basal albumin
excretion rates (Do).
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Table 8. Urinary albumin, /3-2-microglobulin, and light chain excretion (jsg/min) before and after lysine injectiona
Group and
protein excreted
Lysine
Mean of 2 injection
preperiods period
Postinjection periods
1 2 3 4 5 6 7
Normal subjects (N 9)
Albumin 6.7 137.8 199.2 105.3 55.8 29.1 11.8 8.0 6.0
±3.3 ±44 ±52 ±41 ±38 ±32 ±4.8 ±3.3 ±2.4
/3-2-micro 0.066
±0.030
52.8
±23
93.8
±18
74.5
±20
51.7
17
32.9
±23
7.7
±7.4
2,1
±2.4
0.30
±0.19
Light chains 8.3
±3.7
71.5
±31
110.9
±33
94.9
±28
74.9
±21
63.7
±26
45.7
±24
21.1
±17
10.9
±4.0
B(N=8)
Albumin 6.2
±3.5
125.4
±26
182.4
±28
103.1
±38
56.5
±31
27.4
±24
12.5
±12
6.3
±3.4
5.6
±2.5
13-2-micro 0.055
±0.017
61.1
±17
89.5
±20
61.8
±21
45.0
±25
23.6
±20
7.6
±6.7
1.4
±1.7
0.21
±0.12
Light chains 9.4
±3.8
70.7
±29
113.0
±40
80.6
±32
70.7
±26
53.8
±18
34.8
±9.4
24.1
±8.2
12.8
±2.9
C (N = 14)
Albumin 6.6
±4.8
161.7
±81
224.8
±86
100.7
±46
53.1
±40
19.4
±12
9.2
±5.8
5.4
±3.6
5.7
±5.2
/3-2-micro 0.068
±0.023
66.5
±21
98.9
±30
69.5
±21
47.9
±22
20.5
±11
7.4
±4.4
1.9
±1.4
0.44
±0.4
Light chains 12.2
±7.3
82.3
±26
114.4
±35
96.1
±31
91.9
±34
66.2
±27
54.0
±30
34.0
±14
25.2
±18.lc
D (N =6)
Albumin 46.6
18b
276.4
±102
366.8
±108
255.4
±94
140.3
±57
104.7
±52
81.3
±67
46.9
±12
46.6
±8
/3-2-micro 0.094
±0.078
61.9
±16
99.6
±17
78.8
±23
50.7
±8
27.0
±10
10.5
±8
2.2
±1.6
0.42
±0.2
Light chains 12.6
±5.7
65.0
±14
109.9
±44
94.8
±24
76.7
±15
73.4
±22
54.1
±21
29.8
±13
19.8
±7.0
E (N = 4)
Albumin 195.7 640.7 633.1 499.5 469.9 381.9 305.3 301.2 297.0
65b ±96 ±115 ±140 ±214 ±240 ±185 ±191 ±157
/3-2-micro 0.102
±0.077
85.6
±13
113.4
±17
84.9
±29
58.3
±30
36.4
±35
16.3
±15
5.6
±5
0.98
±0.76
Light chains 11.2
±4.2
73.1
±22
99.6
±19
95.6
±18
83.4
±20
70.1
±17
41.9
±6.4
36.7
±11.3
21.5
±7.6e
a Values are means ± sn. Groups are defined in Tables 1 to 7 and in text.
b Increased by definition, subsequent values after lysine significantly increased.
P <0.01, different from normal values.
amounts of albumin. No significant alteration was
found in the peak excretion values of beta-2-micro-
globulin and light chains after lysine injection in any
of the diabetic groups (Table 8). In the final period,
the light chain and beta-2-microglobulin excretion
was not quite normalized, as can be seen from the
table. Serum concentrations, measured in the first
postinjection period, were 6.6 ± (SD) 1.3 mmoles/
liter in 9 diabetic patients and 6.9 ± (SD) 1.5
mmoles/liter in 6 normal subjects. Thus, similar
concentration levels were obtained in normal sub-
jects and in patients with diabetes. In 11 patients
with normal baseline excretion rates, both tests
were performed. No significant correlation was
found between the maximal responses of the two
tests.
Discussion
The present study demonstrates that physical ex-
ercise is able to disclose functional renal abnormal-
ities early in the course of diabetes, in patients with
normal baseline albumin excretion, many years be-
fore nephropathy is clinically evident, confirming
our recent observations [5]. The present results
show that the abnormalities in albumin excretion
emerging during the exercise test are found more
frequently with increasing duration of the disease
and furthermore that the abnormalities are more
pronounced when the baseline albumin values are
slightly to moderately increased. In the early state,
in patients having diabetes less than 2 years, no in-
crease in albumin excretion is found with the exer-
cise loads used, just as in the control subjects.
In addition to describing the evolution of changes
with increasing duration of diabetes, the present
study also provides information on the mechanism
of the abnormal albumin excretion during exercise,
which was not elucidated clearly in our previous in-
vestigation [5]. Our present results show that abnor-
mal albumin excretion occurs independently of the
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I D DC Do DE
Fig. 4. Peak values of albumin excretion rates after lysine injec-
tion. N denotes normal subjects; DB, patients with diabetes 2 to
11 years; D, patients with diabetes 16 to 20 years; DD, patients
with diabetes and with elevated basal albumin excretion rates
of 25 to 100 /sg/min; D, patients with diabetes and with basal
albumin excretion rates of 101 to 300 Lg/min.
changes in the systemic circulation, because diabet-
ics with normal responses in heart rate and blood
pressure also respond abnormally with regard to al-
bumin excretion. Karlefors [12] earlier found abnor-
mal increases in blood pressure and heart rate dur-
ing exercise in a large group of long-term diabetic
patients and mainly in those with overt nephropathy
as indicated by proteinuria. The changes are there-
fore likely to be dependent upon renal abnormalities
in diabetes. Proteinuria may generally be grouped
as due to either increased glomerular permeability
or to decreased tubular reabsorption, each defect
having a typical pattern of albumin, beta-2-micro-
globulin, and light chain excretion [7, 13].
That no increase was found in either the freely
filtered beta-2-microglobulin or in light chain excre-
tion during exercise clearly indicates that the in-
creased albumin excretion during the test is due to
increased glomerular permeability. A possible ex-
planation is that the glomerular filter becomes leaky
in diabetic patients during exercise, when increased
filtration pressure operates, whereas the albumin
molecules are retained under the pressure condi-
tions of the resting state.
50 100 150 200 250 300
Basal albumin excretion, pg/rn/n
Fig. 5. Peak values of albumin excretion rates plotted against
baseline values in JO patients with elevated baseline values.
The definitive filtration barrier to macromole-
cules in the glomerulus has not been defined yet,
but an abnormal increase in the basement mem-
brane is the first lesion to be found in the glomeruli
in diabetes [4], and an abnormal structure and bio-
chemistry of this membrane are likely to be sub-
strate for the functional changes observed in this
study.
The exact increase in GFR of albumin during ex-
ercise is not defined in the present study. Probably
also, an increase in the tubular reabsorption of albu-
min takes place during the test. In patients with
chronically abnormal baseline values, partial inhibi-
tion of reabsorption is able to increase net urinary
excretion by a factor of about 7. Administration of
lysine during the exercise test would disclose
whether similar results were obtained in this partic-
ular situation with acute elevation of GFR of plasma
proteins. Nearly completed studies (Vittinghus and
Mogensen, to be published) on renal hemodynamics
during exercise indicate that changes in GFR and
RPF run parallel in normal and diabetics during
exercise. An exaggerated response in this respect
can therefore be excluded as an explanation for the
abnormal albumin excretion found in diabetes. The
duration and intensity of work used in this study
were based on preliminary experiments, but now a
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detailed study on the exact relationship between
work load, as well as duration of exercise, and in-
crease in protein excretion in normal subjects and
diabetic patients is in progress in our laboratory.
Our preliminary results suggest that an extention of
the 600 kmp/min period to 30 mm increases the
sensitivity of the test.
It is well known, of course, that measurements of
the urinary excretion of proteins (for example, albu-
min) provide no certain information on the glomeru-
lar filtration of these substances, because an un-
known amount of filtered plasma proteins is reab-
sorbed by the tubular cells [7, 13]. The discovery
that arginine and certain other amino acids interfere
with tubular protein reabsorption has opened new
possibilities in this field. If complete blockade Of
tubular protein reabsorption were possible by injec-
tion of certain amino acids, determination of the
GFR of plasma protein would be possible. Recent
investigations have indicated that complete inhibi-
tion is not generally feasible at present [7, 8].
The strongest inhibitory effect was found by ly-
sine, used in the present study in a dose inducing a
partial inhibition of tubular protein reabsorption.
As can be seen in Table 8 and Fig. 4, only patients
with an abnormal baseline albumin excretion re-
sponded with abnormally high values to lysine,
whereas patients with normal baseline values exhib-
ited responses of the same order as control sub-
jects. It should be noted, however, that a few of the
long-term diabetics with normal baseline values re-
sponded with excretion rates greater than those of
the normal group. Considered as a group, however,
no significant changes were established. A signifi-
cant correlation was found between baseline values
and peak values in the group of patients with ele-
vated prevalues. In the normal subjects and in the
patients with baseline values in the normal range,
no significant correlation was found. These findings
suggest that increased baseline values of albumin
are explained by increased GFR of this molecule,
which is also indicated by their low baseline beta-
2-microglobulin excretion.
The effect of lysine on protein excretion is prob-
ably exclusively due to inhibition of reabsorption
without any contributory effect on charge-induced
increase in glomerular permeability, because a typi-
cal pattern of "tubular proteinuria" [13] is found al-
so with higher doses of lysine [7].
Increases in beta-2-microglobulin and light chain
excretion were not significantly altered during the
lysine test in the diabetic patients. Differences in
the tubular response to lysine is therefore difficult to
imagine as being the cause of the increase in albu-
min excretion.
It should be stressed that complete inhibition of
tubular protein reabsorption is not obtained by the
present test, and the results can therefore only be
considered as an index of glomerular passage of al-
bumin.
Comparing the two provocation tests, we con-
clude that the exercise test is much more sensitive,
being able to demonstrate changes early in the
course of diabetes. Definitive abnormalities in the
lysine test are found only in patients with elevated
baseline albumin excretion. In these patients, exer-
cise also induces pronounced changes. The use of
the described provocation tests as a predictive ex-
amination for overt proteinuria and nephropathy is
now being studied in our laboratory.
Finally, it should be mentioned that a new stimu-
lus for increasing albumin excretion has just recent-
ly been established. It appears that acute intra-
venous injection of insulin in diabetics, causing a
fall in blood glucose, but not hypoglycemia, stimu-
lates urinary albumin excretion by increasing the
glomerular filtration of this substance [14]. This ef-
fect, which is being studied in detail now, might also
become useful as a provocative test for early renal
abnormalities.
Summary
The development of functional changes in the
kidney in juvenile diabetes, prior to overt nephropa-
thy, was studied by the use of two test provoking
the increase in urinary protein excretion, namely
physical exercise and lysine injection. Urinary ex-
cretion of albumin, beta-2-microglobulin, and light
chain excretion was measured. Thirty-seven young
male diabetics and eleven control subjects were
studied by the exercise test (450 kpm/min for 20 mm
followed by 600 kmp/min for 20 or 30 mm). In nor-
mal subjects, no increase in albumin excretion was
found. Similar results were obtained in patients
having had diabetes for 1 year or less. In patients,
however, with diabetes for 2 to 20 years and with
normal baseline excretion, significant increases in
albumin excretion were demonstrated, as evidence
of abnormal glomerular permeability during exer-
cise, where increased filtration pressure may occur.
Thus, during exercise, changes are disclosed that
are not demonstrable during baseline conditions.
The changes in albumin excretion occurred inde-
pendent of changes in heart rate and blood pres-
sure. No increase in beta-2-microglobulin or light
chain excretion was noted in any of the subjects in-
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dicating that tubular protein reabsorption was un-
disturbed during the exercise load. Patients with in-
creased baseline values exhibited still higher in-
creases in albumin excretion during exercise.
Thirty-two young male diabetic patients and nine
control subjects were studied by the lysine test.
Lysine, 0.4 glkg body wt, was injected i.v. A
sharp rise in beta-2-microglobulin excretion after ly-
sine by a factor of 1440 occurred in the normal sub-
jects, whereas albumin excretion increased only by
a factor of 30, a clear indication of inhibition of
tubular protein reabsorption. No significant change
in the response was noted in the diabetic patients
with normal baseline albumin values, irrespective
of duration of diabetes. Only patients with elevated
baseline values responded with abnormally high al-
bumin values after lysine, whereas the beta-2-mi-
croglobulin and light chain responses were normal,
indicating increased glomerular permeability. It is
concluded that the exercise test is the more sensi-
tive test of the two because abnormalities, probably
of glomerular origin, can be demonstrated early in
the course of diabetes.
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